Merck has named a new head of research. Roger Perlmutter steps into the roles of executive vice president and president of Merck Research Laboratories. He replace of the retiring Peter Kim, effective April 15.
Perlmutter worked at Amgen for over a decade, serving in various positions from early 2001 to February 2012. Most recently, he was head of R&D at that company. Prior to his tenure at Amgen, he worked as a professor at the University of Washington, where he also was chairman of the department of immunology.
Kim, who Merck says will remain as an advisor to the company after Perlmutter's ascension, is to retire in August.
The article Merck Appoints New Research Head originally appeared on Fool.com.
Fool contributor Eric Volkman has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.